Two-Year Treatment Outcomes of Simultaneous Intravitreal Dexamethasone and Aflibercept on Diabetic Macular Edema
Simultaneous intravitreal DEX and aflibercept treatment resulted in sustained improvements in both visual and anatomical outcomes over a 24-month period. This combination therapy represents a valid treatment strategy and demonstrates synergistic efficacy in the management of DME.
Authors
- Chen-Yu Chao
- Sheng-Chu Chi (ORCID: https://orcid.org/0000-0002-2544-2353)
- Tsui-Kang Hsu
- Tai-Chi Lin
- Po-Chen Tseng
- Yi-Ming Huang
- Yu-Chien Chung
- Hsin-Wei Huang
Institutions
- Fu Jen Catholic University (TW)
- National Chung Cheng University (TW)
- National Yang Ming Chiao Tung University (TW)
- National Taiwan University (TW)
- University of Kang Ning (TW)
- University of Taipei (TW)
- Taipei Veterans General Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- Cheng Hsin General Hospital (TW)
- Taipei City Hospital (TW)
- Wan Fang Hospital (TW)
- Taipei Medical University (TW)
- National Taipei University (TW)
Publication Details
- Journal
- Ophthalmologica
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1159/000550320
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00